Biohaven (BHVN) Assets Average (2022 - 2026)
Biohaven's (BHVN) quarterly Assets Average came in at $458.9 million in Q1 2026, down 14.54% year-on-year from $537.0 million in Q1 2025, and up 6.66% quarter-over-quarter from $430.3 million in Q4 2025.
Biohaven (BHVN) Assets Average (2022 - 2026) Analysis & Trends
Biohaven has disclosed Assets Average across 5 years of filings, most recently posting $458.9 million for Q1 2026.
- Assets Average for Q1 2026 came in at $458.9 million, down 14.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $458.9 million (down 14.54% YoY), and the FY2025 annual result was $533.3 million, down 5.47% from the prior year.
- Assets Average came in at $458.9 million for Q1 2026 at Biohaven, up from $430.3 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $640.2 million in Q1 2023 to a low of $398.7 million in Q4 2022.
- The 5-year median for Assets Average is $490.2 million (2024), against an average of $498.6 million.
- Peak annual rise in Assets Average reached 25.64% in 2024, while the deepest fall reached 27.22% in 2024.
- Biohaven's Assets Average stood at $398.7 million in 2022, then advanced by 12.35% to $448.0 million in 2023, then increased by 25.64% to $562.8 million in 2024, then fell by 23.55% to $430.3 million in 2025, then advanced by 6.66% to $458.9 million in 2026.
- The last three Assets Average figures came in at $458.9 million (Q1 2026), $430.3 million (Q4 2025), and $479.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 660.38 Mn |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - | 458.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 458.93 Mn |
| Dec 31, 2025 | 430.29 Mn |
| Sep 30, 2025 | 479.77 Mn |
| Jun 30, 2025 | 504.68 Mn |
| Mar 31, 2025 | 537.03 Mn |
| Dec 31, 2024 | 562.82 Mn |
| Sep 30, 2024 | 546.58 Mn |
| Jun 30, 2024 | 500.59 Mn |
| Mar 31, 2024 | 465.87 Mn |
| Dec 31, 2023 | 447.97 Mn |
| Sep 30, 2023 | 444.74 Mn |
| Jun 30, 2023 | 562.63 Mn |
| Mar 31, 2023 | 640.15 Mn |
| Dec 31, 2022 | 398.71 Mn |